Literature DB >> 22943542

Amphotericin B still in the headlines.

Luigina Romani1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22943542      PMCID： PMC4001492          DOI： 10.1179/204777312X13419245939566

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN： 2047-7724            Impact factor:   2.894


× No keyword cloud information.
  4 in total

Review 1.  Antifungal agents: mechanisms of action.

Authors:  Frank C Odds; Alistair J P Brown; Neil A R Gow
Journal:  Trends Microbiol       Date:  2003-06       Impact factor: 17.079

2.  Amphotericin primarily kills yeast by simply binding ergosterol.

Authors:  Kaitlyn C Gray; Daniel S Palacios; Ian Dailey; Matthew M Endo; Brice E Uno; Brandon C Wilcock; Martin D Burke
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

3.  Natamycin inhibits vacuole fusion at the priming phase via a specific interaction with ergosterol.

Authors:  Yvonne Maria te Welscher; Lynden Jones; Martin Richard van Leeuwen; Jan Dijksterhuis; Ben de Kruijff; Gary Eitzen; Eefjan Breukink
Journal:  Antimicrob Agents Chemother       Date:  2010-04-12       Impact factor: 5.191

4.  Probing amphotericin B single channel activity by membrane dipole modifiers.

Authors:  Olga S Ostroumova; Svetlana S Efimova; Ludmila V Schagina
Journal:  PLoS One       Date:  2012-01-19       Impact factor: 3.240
  4 in total
  3 in total

Review 1.  Challenges in the Polyene- and Azole-Based Pharmacotherapy of Ocular Fungal Infections.

Authors:  Prit Lakhani; Akash Patil; Soumyajit Majumdar
Journal:  J Ocul Pharmacol Ther       Date:  2018-11-08       Impact factor: 2.671

2.  A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts.

Authors:  Matteo Bassetti; Monia Marchetti; Arunaloke Chakrabarti; Sergio Colizza; Jose Garnacho-Montero; Daniel H Kett; Patricia Munoz; Francesco Cristini; Anastasia Andoniadou; Pierluigi Viale; Giorgio Della Rocca; Emmanuel Roilides; Gabriele Sganga; Thomas J Walsh; Carlo Tascini; Mario Tumbarello; Francesco Menichetti; Elda Righi; Christian Eckmann; Claudio Viscoli; Andrew F Shorr; Olivier Leroy; George Petrikos; Francesco Giuseppe De Rosa
Journal:  Intensive Care Med       Date:  2013-10-09       Impact factor: 17.440

3.  Funding and Innovation in Diseases of Neglected Populations: The Paradox of Cryptococcal Meningitis.

Authors:  Marcio L Rodrigues
Journal:  PLoS Negl Trop Dis       Date:  2016-03-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.